Sanctus Global Formulation
Sanctus Global Formulation Limited is a privately held Indian pharmaceutical manufacturer (Chandigarh HQ, WHO-GMP facility in Baddi) producing oral solid dosage generics — tablets, capsules, and granules — sold through a PCD pharma franchise network, contract manufacturing, and direct sales via its Lifesciences marketing arm.
- Company typePrivate
- Founded2016
- HeadquartersChandigarh, India
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Sanctus Global Formulation does
Sanctus Global Formulation Limited is a privately held Indian pharmaceutical company headquartered in Chandigarh with a WHO-GMP, GMP, ISO, and DCGI-certified manufacturing facility in Baddi, Himachal Pradesh. It operates as the manufacturing arm of the Sanctus Global Group, while a wholly owned subsidiary, Sanctus Global Lifesciences Pvt. Ltd., functions as the marketing and distribution arm. The company specializes in oral solid dosage forms — tablets, capsules, direct compression granules, and pellets — supported by in-house formulation development teams and a quality analysis laboratory, and claims a portfolio of 600+ branded generic products spanning therapeutic categories including antibiotics, analgesics, gastrointestinal, cardiovascular, anti-diabetic, dermatology, gynaecology, orthopaedics, paediatrics, and nutritional supplements (e.g., brands such as ACLOSAN, AZITHROTUS, CIPROTUS, PANTOSAIN, SANOJOINT, and METFORTUS).
The company generates revenue through four streams: (i) PCD (Propaganda Cum Distribution) pharma franchise, where partners acquire exclusive monopoly distribution rights for designated Indian territories at an estimated INR 25,000-50,000 per district; (ii) contract / third-party manufacturing of tablets, capsules, and granules for other pharmaceutical companies under private label; (iii) direct branded sales of generic medicines via Sanctus Global Lifesciences to hospitals, clinics, and pharmacies across 15+ Indian cities; and (iv) regulatory affairs services supporting compliance and submissions for clients. The go-to-market blends a long-tail franchise channel, an enterprise contract-manufacturing channel, and direct sales, supported by SEO-driven content marketing, social media presence, participation in industry events (IPHEX 2024, CPHI 2024), and standard promotional materials supplied to franchise partners.
The company is led by Mr. V. Kumar Joshi (Managing Director) and Mr. Sahil Joshi (CEO & Director). It reports 101-250 employees, was founded in 2016 per firmographic data, is privately held with no disclosed institutional funding, and discloses no revenue, international operations, or material M&A activity. There is no evidence of AI/ML, proprietary technology platforms, or unique digital products; the competitive position is grounded in regulatory credentials, the breadth of the product catalog, and the established franchise distribution footprint in India.
Sanctus Global Formulation firmographics
Firmographics- Name
- Sanctus Global Formulation
- Legal name
- Sanctus Global Formulation Limited
- Website
- https://sanctusglobal.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Sanctus Global Formulation Limited is a privately held Indian pharmaceutical manufacturer (Chandigarh HQ, WHO-GMP facility in Baddi) producing oral solid dosage generics — tablets, capsules, and granules — sold through a PCD pharma franchise network, contract manufacturing, and direct sales via its Lifesciences marketing arm.
- Ownership category
- akta.pro rank
Sanctus Global Formulation industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
- akta.pro secondary industries
- Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
Keywords
Where Sanctus Global Formulation is headquartered
LocationHeadquarters
- HQ city
- Chandigarh
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
Sanctus Global Formulation business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- PCD Pharma Franchise: The company generates revenue by granting PCD pharma franchise rights to distribution partners who market and sell Sanctus Global's pharmaceutical products under the company's brand within exclusive territories. Franchise partners pay for the rights and purchase stock, generating margin revenue.
- Contract / Third-Party Manufacturing: Sanctus Global manufactures pharmaceutical products on behalf of other pharmaceutical companies (third-party/contract manufacturing), providing end-to-end production of tablets and capsules under client brand names or private label.
- Pharmaceutical Product Sales: Direct sales of branded pharmaceutical products across therapeutic categories (antibiotics, analgesics, GI, cardiovascular, etc.) through its marketing arm Sanctus Global Lifesciences Pvt. Ltd., serving hospitals, clinics, and healthcare facilities.
- Regulatory Affairs Services: The company offers regulatory affairs services as part of its business portfolio, assisting other pharma companies with compliance and regulatory submissions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | PCD Pharma Franchise — Entry-Level Investment (India) |
| One time/ perpetual license | Multi-year contract | PCD Pharma Franchise — Standard Investment (India) |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Sanctus Global Formulation product offering
Product offeringCore offering
Sanctus Global Formulation manufactures oral solid dosage pharmaceutical forms (tablets, capsules, direct compression granules, and pellets) across 600+ branded generic products in therapeutic categories including antibiotics, analgesics, gastrointestinal, cardiovascular, anti-diabetic, and neurological medicines. The company sells its manufactured products through a PCD (Propaganda Cum Distribution) Pharma Franchise model granting exclusive territory rights to franchise partners, and offers contract manufacturing services to other pharmaceutical companies seeking WHO-GMP certified third-party production. It also provides formulation development and regulatory affairs services as adjunct offerings.
Product overview
Sanctus Global Formulation is a pharmaceutical company offering contract manufacturing services and PCD pharma franchise opportunities. The company operates with four core service/product areas: Contract Manufacturing Services for third-party pharmaceutical production, Formulation Development for drug design and optimization, Regulatory Affairs for compliance and approvals, and PCD Pharma Franchise for marketing distribution rights. Their manufacturing focuses on oral solid dosage forms including tablets and capsules in various therapeutic categories including analgesics, antibiotics, gastro-intestinal, cardiovascular, anti-diabetic, and neurological products. The company produces branded generic pharmaceutical products sold under various brand names including ACLOSAN, AZITHROTUS, BETASAN, CIPROTUS, LEVOSAN, NIMUTUS, OFLOSAN, PANTOSAIN, PREGATUS, REBOZOLE, SANCICAL, SANDAZOLE, SANOJOINT, SANCTALOL, METFORTUS, and others, available in tablet, capsule, and strip/blister packaging formats.
Differentiator
Problem solved
Functional benefit
Brands
- Sanctus Global Lifesciences: The marketing arm of the Sanctus Global Group, distributing a wide range of branded pharmaceutical products across India.
Products and services
- Contract Manufacturing Services Third-party and contract pharmaceutical manufacturing of oral solid dosage forms — tablets, capsules, direct compression granules, and pellets — produced under WHO-GMP certified facilities in Baddi, Himachal Pradesh for other pharmaceutical companies under client brand names or private labels. Includes in-house quality analysis laboratory support.
- Formulation Development Services Research and development services for designing and optimizing drug formulations across multiple delivery mechanisms including tablets, capsules, and granules. In-house formulation development teams support custom formulation development and private labeling needs.
- Regulatory Affairs Services Regulatory compliance and affairs management services supporting pharmaceutical product approvals and market authorization, including assistance with submissions for other pharmaceutical companies.
- PCD Pharma Franchise Propaganda Cum Distribution (PCD) pharma franchise business offering exclusive monopoly rights for marketing and distributing Sanctus Global's pharmaceutical products within designated Indian territories. Franchise partners receive promotional materials (visual aids, MR bags, diaries, prescription pads, reminder cards, pens, chemist order books), product training, and marketing support.
- Branded Pharmaceutical Product Portfolio (Generic Medicines) Portfolio of 600+ branded generic pharmaceutical products across therapeutic categories including antibiotics (AZITHROTUS, CIPROTUS, LEEVOFLOX, OFLOSAN), analgesics/NSAIDs (ACLOSAN, NIMUTUS, PARATUS, SANOFLAM, SANCTUS RELIEF, ACESAN), gastrointestinal (ESOSAN-DSR, PANTOSAIN, REBOZOLE, SANOZOLE), cardiovascular (SANCTALOL, METATUS, RASUTUS), anti-diabetic (METFORTUS, GLIMTUS), anti-allergy (BETASAN, LEVOSAN, FEXOTUS), anthelmintics (SANDAZOLE), joint health (SANCICAL, SANOJOINT), neurological (PREGATUS, MIRZATTUS, PRE-75), and others. Products are tablets, capsules, and pellets available in blister/strip packaging, supplied via franchise network and direct sales.
Quantifiable outcome
- Manufacturing capacity across tablets, capsules, direct compression granules, and pellets with WHO-GMP certification
- +2 more outcomes
Companies that use Sanctus Global Formulation
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
Sanctus Global Formulation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Sanctus Global Formulation partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Sanctus Global Lifesciences Pvt. Ltd.coreSanctus Global Lifesciences Pvt. Ltd. is the marketing and distribution arm of the Sanctus Global Group. Originally focused on marketing drugs within the Indian market, it is now expanding to distribute a wide range of branded pharmaceutical products. It functions as Sanctus Global Formulations' primary sales and marketing channel, handling brand promotion and distribution network management.
Scale indicators4 records
Recent moves5 records
Expansion highlights3 records
Sanctus Global Formulation competitors and assessment
Company assessmentBroad incumbents
- Mankind Pharma: One of India's largest pharmaceutical companies with broad generic portfolio, PCD franchise operations, and contract manufacturing. Significantly larger than Sanctus but competes in the same generic therapeutic categories and distribution channels.
- Cipla: Indian multinational pharmaceutical company with extensive generic and OTC portfolio, large CDMO operations, and global distribution. Overlaps with Sanctus in generic oral solid dosage manufacturing and Indian distribution.
- Alkem Laboratories: Indian pharma major with strong generic portfolio across antibiotics, GI, cardiovascular, and anti-diabetic segments — many of the same therapeutic categories Sanctus operates in, plus its own contract manufacturing business.
Direct peers
- Unison Pharmaceuticals: India-based PCD pharma franchise and contract manufacturing company with a comparable generic product portfolio and franchise distribution model. Closest direct competitor in the PCD franchise space among small-to-mid Indian manufacturers.
- Swiss Healthcare: PCD pharma franchise company offering generics with monopoly rights across India, competing directly with Sanctus Global for franchise partners and similar therapeutic categories.
- Mediva Healthcare: Chandigarh/North India-based PCD pharma franchise company offering generic medicines with similar franchise model, territory exclusivity, and product breadth to Sanctus Global.
- Morepen Laboratories: Indian pharmaceutical manufacturer with strong presence in oral solid dosage forms (including generics and OTC) and active in contract manufacturing — comparable scale and product mix to Sanctus Global.
- Indoco Remedies: Indian pharma company specializing in generics and contract manufacturing/research with WHO-GMP facilities, overlapping with Sanctus in formulation development and oral solid dosage manufacturing.
- Zota Healthcare: Indian PCD pharma franchise and generic manufacturing company with comparable franchise model, product breadth, and target market to Sanctus Global.
- Akums Drugs & Pharmaceuticals: India's largest contract development and manufacturing organization (CDMO) for oral solid dosage forms, with WHO-GMP facilities. Directly comparable CDMO competitor to Sanctus's contract manufacturing business.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Sanctus Global Formulation social profiles
Digital presenceSanctus Global Formulation compliance and trust
Trust signalCompliance4 records
Sanctus Global Formulation financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sanctus Global Formulation leadership team
Management profileNumber of profiles
Profiles2 records
Sanctus Global Formulation subsidiaries and ownership
Company hierarchySubsidiaries1 record
Sanctus Global Formulation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sanctus Global Formulation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sanctus Global Formulation
What does Sanctus Global Formulation do?
Sanctus Global Formulation manufactures oral solid dosage pharmaceutical forms (tablets, capsules, direct compression granules, and pellets) across 600+ branded generic products in therapeutic categories including antibiotics, analgesics, gastrointestinal, cardiovascular, anti-diabetic, and neurological medicines. The company sells its manufactured products through a PCD (Propaganda Cum Distribution) Pharma Franchise model granting exclusive territory rights to franchise partners, and offers contract manufacturing services to other pharmaceutical companies seeking WHO-GMP certified third-party production. It also provides formulation development and regulatory affairs services as adjunct offerings.
Is Sanctus Global Formulation a public or private company?
Sanctus Global Formulation is a private company. It is classified as family owned and is currently operating.
When was Sanctus Global Formulation founded?
Sanctus Global Formulation was founded in 2016. It employs 101 to 250 people.
Where is Sanctus Global Formulation based?
Sanctus Global Formulation is headquartered in Chandigarh, India, in the Asia region.
How does Sanctus Global Formulation make money?
Four revenue lines are on record. PCD Pharma Franchise is the primary driver. The others are contract / Third-Party Manufacturing, pharmaceutical Product Sales and regulatory Affairs Services.
Who are Sanctus Global Formulation's main competitors?
Broad incumbents on record are Mankind Pharma, Cipla and Alkem Laboratories. Direct peers are Unison Pharmaceuticals, Swiss Healthcare, Mediva Healthcare, Morepen Laboratories, Indoco Remedies, Zota Healthcare and Akums Drugs & Pharmaceuticals.
Does Sanctus Global Formulation have an API?
No public API is recorded for Sanctus Global Formulation.
What industry is Sanctus Global Formulation in?
Sanctus Global Formulation's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing, with a secondary code of HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO). Its NAICS code is 325412 and its SIC code is 2834.